OPK
HOLD / NEUTRALMeanRevComposite
35.10
Technical
63.00
Fundamental
25.80
Rank
—
Price
1.65
Hurst
0.20
As of
Jul 29, 2026
Daily
OPKO Health, Inc.
HealthcareDiagnostics & ResearchOPKO Health operates as a diversified healthcare company with operations across multiple countries. Its Pharmaceutical segment develops immunotherapy candidates and other drug products, including treatments for solid and blood-based tumors, growth hormone deficiency, metabolic disorders, and an Epstein Barr Virus vaccine. The Diagnostics segment provides laboratory testing services under the BioReference brand, offering clinical tests, molecular diagnostics, pathology, genetics, and specialized screening across various medical areas.
Market cap
$1.2B
P/E (trailing)
—
P/E (forward)
-4.83
PEG ratio
93.65
Dividend yield
0.00%
Beta
1.50
52w range
0.98 – 1.77
Return on equity
-5.88%
Profit margin
-12.40%
Revenue growth
+4.30%
Earnings growth
—
Price history
1Y: 1.66 (+22.1%) · range 1.10–1.73
Cycle position
72/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 9 · NOT READY · exit proximity 0
Conviction
12/ 100 · maturity 0%
Buildup.337
EMA entry setup.429
Fundamentals.2526
Volume profile
POC
1.50
Price vs POC
+10.6%
Overhead supply
10%
Runway
open sky
Value area 1.37–1.67 · 10% of 120d volume overhead · clean runway
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +25.19% | +25.19% | mature |
| 40d | +16.30% | +28.15% | mature |